Semaglutide – 10mg

Semaglutide has been widely discussed across mainstream media and health communities for its role in metabolic function studies. It is frequently compared with Tirzepatide (a dual GIP/GLP-1 agonist) and Retatrutide (a triple agonist) in research settings exploring GLP-1 agonist efficacy differences. Durham Peptides carries all three compounds.

BENEFITS

• Metabolic research — studied for effects on GLP-1 receptor activation and glucose regulation

• Weight management — explored extensively in clinical trial settings for body composition changes

• Appetite signaling — linked to modulation of satiety and hunger pathways

• Cardiovascular — associated with cardiovascular outcome studies in large-scale trials

• Pancreatic function — investigated for beta-cell preservation and insulin secretion pathways

WHAT RESEARCHERS LOOK AT

• GLP-1 receptor binding affinity and activation kinetics

• Comparative efficacy with other GLP-1 agonists (liraglutide, tirzepatide)

• Dose-response curves in metabolic models

• Half-life extension through albumin binding

• Appetite regulation via central and peripheral signaling

QUICK SPECS

• Form: Lyophilized peptide powder

• Net per vial: 10 mg

• Purity: ≥99% (HPLC verified)

• Identity: MS-verified (per COA)

• Storage: 2–8°C, protect from light and moisture

• Reconstitution: Use bacteriostatic water (sold separately)

IDENTITY BASICS

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

• Molecular Weight: 4113.58 g/mol

• CAS: 910463-68-2

• Classification: GLP-1 receptor agonist

WHY CHOOSE DURHAM PEPTIDES FOR SEMAGLUTIDE?

• Janoshik tested with independently verifiable COA keys

• Same-day shipping across Canada (orders before 5:00 PM EST)

• Free shipping on orders over $200 CAD

• 100% vegan — synthetically manufactured, no animal derivatives

• Secure payment via Interac e-Transfer, credit/debit, or Crypto

• $64.99 CAD — competitive Canadian pricing

SELECTED RESEARCH

• Semaglutide oral GLP-1 RA review: https://pubmed.ncbi.nlm.nih.gov/32725484/

• GLP-1 receptor agonists state-of-the-art: https://pubmed.ncbi.nlm.nih.gov/33068776/

• For laboratory research use only.

• Not for human or veterinary use.

• Not intended for diagnosis, treatment, cure, or prevention of any disease.

• Use only in controlled laboratory settings by qualified personnel following appropriate safety procedures.